(19)
(11) EP 1 833 804 A1

(12)

(43) Date of publication:
19.09.2007 Bulletin 2007/38

(21) Application number: 05821963.5

(22) Date of filing: 23.12.2005
(51) International Patent Classification (IPC): 
C07D 261/08(2006.01)
A61K 31/4245(2006.01)
A61P 25/22(2006.01)
A61P 25/34(2006.01)
C07D 271/06(2006.01)
A61K 31/42(2006.01)
A61P 25/18(2006.01)
A61P 25/28(2006.01)
C07D 261/04(2006.01)
(86) International application number:
PCT/SE2005/002037
(87) International publication number:
WO 2006/071184 (06.07.2006 Gazette 2006/27)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 28.12.2004 US 639514 P

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • BROWN, Dean AstraZeneca Wilmington
    Wilmington, DE 19850-5437 (US)
  • MCLAREN, Frances M AstraZeneca Wilmington
    Wilmington, DE 19850-5437 (US)
  • SIMPSON, Thomas Richard AstraZeneca Wilmington
    Wilmington, DE 19850-5437 (US)

(74) Representative: Wahlström, Stig Christer Gunnar 
AstraZeneca Global Intellectual Property
151 85 Södertälje
151 85 Södertälje (SE)

   


(54) ARYL SULPHONAMIDE MODULATORS